Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Notice of alternative medication authorization, November 25, 2021

Legal publication
Updated on

 10 January 2022

This notice was published on January 10, 2022.

Medroxyprogesterone acetate (99113947) replaces:

  • Apo-Medroxy
  • Novo-Medrone
Download (.pdf)
 61.96 KB
Related topics